StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.11+0.12 (+0.75%)

Close on Nov 17, 2026Market cap $2.98BP/E –Yield –

Legend Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Legend Biotech's price to sales ratio was 2.9× on Nov 11, 2026, against 5.6× a year earlier. Over the last 5 years it ranged from 2.9× to 112.6×, with a median of 27.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.9×−1.5
2025Dec 31, 20254.4×−7.0
2024Dec 31, 202411.4×−32.9
2023Dec 29, 202344.3×−57.8
2022Dec 30, 2022102.2×+28.7
2021Dec 31, 202173.4×+26.5
2020Dec 31, 202046.9×–

More Legend Biotech figures

See a number that looks wrong?